Department of Surgical, Oncological and Gastroenterological Sciences, University of Padova, School of Medicine, Padova, Italy.
Department of Surgical, Oncological and Gastroenterological Sciences, University of Padova, School of Medicine, Padova, Italy.
Dig Liver Dis. 2018 Apr;50(4):342-347. doi: 10.1016/j.dld.2017.11.012. Epub 2017 Nov 26.
It is currently unclear if the three manometric patterns of esophageal achalasia represent distinct entities or part of a disease continuum. The study's aims were: a) to test the hypothesis that the three patterns represent different stages in the evolution of achalasia; b) to investigate whether manometric patterns change after Laparoscopic-Heller-Dor (LHD).
We assessed the patients diagnosed with achalasia who underwent LHD as their first treatment from 1992 to 2016. Their symptoms were scored using a detailed questionnaire for dysphagia, food-regurgitation, and chest pain. Barium-swallow, endoscopy, and esophageal-manometry were performed before and 6 months after surgery.
The study population consisted of 511 patients (M:F=283:228). Patients' demographic and clinical data showed that those with pattern III had a shorter history of symptoms, a higher incidence of chest pain, and a less dilated gullet (p<0.001). All patients with a sigmoid-shaped mega-esophagus had pattern I achalasia. One patient with a diagnosis of pattern III achalasia developed pattern II at a follow-up manometry before surgery. At a median follow-up of 30 months (IQR 12-56), the outcome of surgery was positive in 479 patients (91.7%). All patients with pattern I preoperatively had the same pattern after LHD, whereas more than 50% of patients with pattern III before treatment showed pattern I or II after surgery.
This study supports the hypothesis/theory that the different manometric patterns represent different stages in the evolution of the disease-where pattern III is the earliest stage, pattern II an intermediate stage, and pattern I the final stage.
目前尚不清楚食管失弛缓症的三种测压模式是否代表不同的实体或疾病连续体的一部分。本研究的目的是:a)检验三种模式代表贲门失弛缓症演变的不同阶段的假设;b)研究腹腔镜 Heller-Dor(LHD)手术后测压模式是否发生变化。
我们评估了 1992 年至 2016 年间因首次接受 LHD 治疗而被诊断为贲门失弛缓症的患者。他们的症状通过详细的吞咽困难、食物反流和胸痛问卷进行评分。钡餐、内镜和食管测压在手术前和手术后 6 个月进行。
研究人群包括 511 例患者(男:女=283:228)。患者的人口统计学和临床数据显示,III 型患者的症状史较短、胸痛发生率较高、食管扩张程度较轻(p<0.001)。所有具有乙状结肠型巨食管的患者均为 I 型贲门失弛缓症。1 例 III 型贲门失弛缓症患者在术前测压随访中发展为 II 型。中位随访 30 个月(IQR 12-56),479 例(91.7%)患者手术效果良好。所有术前 I 型患者 LHD 后仍为 I 型,而术前 3 型患者中超过 50%术后表现为 I 型或 II 型。
本研究支持不同测压模式代表疾病演变不同阶段的假设/理论,其中 III 型为最早阶段,II 型为中间阶段,I 型为最终阶段。